Key facts
- Triangle Health’s last known valuation is $25.0M (Mar 2026).
- It has raised $4.0M; the latest was Seed Round ($4.0M) in Mar 2026.
- Notable investors include Antler, SNR, Hannah Grey Ventures, John Hering, Kestrin Pantera — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Triangle Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Triangle Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Triangle Health
Developer of a consumer health artificial intelligence platform designed to identify relevant treatment options and clinical pathways for patients. The company's platform offers aggregation of medical records with literature and clinical trial analysis, enabling patients and healthcare providers to match conditions with research insights and care options.
- Sector
- Healthcare
- HQ
- Pasadena, CA, United States
- Founded
- 2024
- Employees
- 5
- Website
- trianglehealth.com/
- Ownership
- Privately Held (backing)
Triangle Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Triangle Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Triangle Health in its N-PORT filings yet. We sweep new filings monthly.